Status:
COMPLETED
Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Parkinson Disease
Eligibility:
All Genders
45-99 years
Phase:
NA
Brief Summary
The purpose of this pilot study is to generate preliminary data on the impact of the dietary protein pattern on markers of skeletal muscle health and drug efficacy in Parkinson disease.
Detailed Description
Parkinson's disease (PD) is a complex neurological disease that affects \~6.1 million people worldwide - mostly older adults \>60 years. The most effective treatment for PD is dopaminergic therapy, pa...
Eligibility Criteria
Inclusion
- Clinical diagnosis of idiopathic PD for 5 or more years
- 45 years or older
- On a stable levodopa regimen for 3 or more months
- Self-reported to experience motor fluctuations
Exclusion
- Following a specific diet that would preclude participation
- Renal disease
- Deep brain stimulation
- Known narcolepsy
- Untreated sleep apnea
- Any condition that, in the opinion of the investigator, will preclude the participant from successfully or safely completing study procedures
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05437640
Start Date
October 1 2022
End Date
November 25 2024
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233